150 related articles for article (PubMed ID: 34926693)
1. lncRNA FGD5-AS1 and miR-130a Can Be Used for Prognosis Analysis of Patients with Chronic Periodontitis.
Yu M; Chi C
Biomed Res Int; 2021; 2021():8544914. PubMed ID: 34926693
[TBL] [Abstract][Full Text] [Related]
2. Abnormal expression of long noncoding RNA FGD5-AS1 affects the development of periodontitis through regulating miR-142-3p/SOCS6/NF-κB pathway.
Chen H; Lan Z; Li Q; Li Y
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2098-2106. PubMed ID: 31144533
[TBL] [Abstract][Full Text] [Related]
3. Targeting the lncRNA FGD5-AS1/miR-497-5p/PD-L1 Axis Inhibits Malignant Phenotypes in Colon Cancer (CC).
Zhang L; Cai X; Dai Y; Chen Y; Yu J; Zhou Y
Biomed Res Int; 2022; 2022():1133332. PubMed ID: 35845947
[TBL] [Abstract][Full Text] [Related]
4. LncRNA FGD5-AS1/miR-5590-3p axis facilitates the proliferation and metastasis of renal cell carcinoma through ERK/AKT signalling.
Yang Y; Dong MH; Hu HM; Min QH; Xiao L
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8756-8766. PubMed ID: 32964964
[TBL] [Abstract][Full Text] [Related]
5. LncRNA FGD5-AS1 promotes the malignant phenotypes of ovarian cancer cells via targeting miR-142-5p.
Aichen Z; Kun W; Xiaochun S; Lingling T
Apoptosis; 2021 Jun; 26(5-6):348-360. PubMed ID: 33974163
[TBL] [Abstract][Full Text] [Related]
6. lncRNA FGD5-AS1 acts as a ceRNA to regulate lipopolysaccharide-induced injury via the miR-223-3p-3p/GAS5 axis in cardiomyocytes.
Fang XL; Shi SG
Hum Exp Toxicol; 2022; 41():9603271221138969. PubMed ID: 36445031
[TBL] [Abstract][Full Text] [Related]
7. Long Noncoding RNA FGD5-AS1 Knockdown Decrease Viability, Migration, and Invasion of Non-Small Cell Lung Cancer (NSCLC) Cells by Regulating the MicroRNA-944/MACC1 Axis.
Lv J; Li Q; Ma R; Wang Z; Yu Y; Liu H; Miao Y; Jiang S
Technol Cancer Res Treat; 2021; 20():1533033821990090. PubMed ID: 33550920
[TBL] [Abstract][Full Text] [Related]
8. LncRNA FGD5-AS1 Alleviates Inflammation in Allergic Rhinitis through the miR-223-3p/COX11 Axis.
Li B; Yu X; Pang F
Int Arch Allergy Immunol; 2024; 185(3):201-211. PubMed ID: 38071964
[TBL] [Abstract][Full Text] [Related]
9. Expression of lncRNA FGD5-AS1 correlates with poor prognosis in melanoma patients.
Gao Y; Zhu H; Mao Q
J Gene Med; 2020 Dec; 22(12):e3278. PubMed ID: 32997827
[TBL] [Abstract][Full Text] [Related]
10. Silencing of Long Non-Coding RNA FGD5-AS1 Inhibits the Progression of Non-Small Cell Lung Cancer by Regulating the miR-493-5p/DDX5 Axis.
Cui F; Luo P; Bai Y; Meng J
Technol Cancer Res Treat; 2021; 20():1533033821990007. PubMed ID: 33550957
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA FGD5 antisense RNA 1 targets Baculovirus inhibitor 5 via microRNA-497-5p to alleviate calcific aortic valve disease.
Wei J; Zhu X; Sun A; Yan X; Meng X; Ge S
Clin Hemorheol Microcirc; 2024; 86(3):285-302. PubMed ID: 37355887
[TBL] [Abstract][Full Text] [Related]
12. lncRNA FGD5-AS1 Regulates Bone Marrow Stem Cell Proliferation and Apoptosis by Affecting miR-296-5p/STAT3 Axis in Steroid-Induced Osteonecrosis of the Femoral Head.
Wu Y; Fang L; Gao Y; Zhao Z; Zhou L; Zhang G
J Healthc Eng; 2022; 2022():9364467. PubMed ID: 35190765
[TBL] [Abstract][Full Text] [Related]
13. Abnormal expression of long non-coding RNA FGD5-AS1 affects the development of ovarian cancer through regulating miR-107/RBBP6 axis.
Zhang W; Shi J; Liu G
Chin J Physiol; 2023; 66(3):171-180. PubMed ID: 37322627
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA FGD5-AS1 enhances osteosarcoma cell proliferation and migration by targeting miR-506-3p/RAB3D axis.
Li C; Lin X; Zhang C; Wan L; Yin J; Wang B
Hum Cell; 2021 Jul; 34(4):1255-1265. PubMed ID: 33891267
[TBL] [Abstract][Full Text] [Related]
15. The LncRNA FGD5-AS1/miR-497-5p axis regulates septin 2 (SEPT2) to accelerate cancer progression and increase cisplatin-resistance in laryngeal squamous cell carcinoma.
Song K; Yu P; Zhang C; Yuan Z; Zhang H
Mol Carcinog; 2021 Jul; 60(7):469-480. PubMed ID: 34003510
[TBL] [Abstract][Full Text] [Related]
16. The role of long non-coding RNA FGD5-AS1 in cancer.
He N; Xiang L; Chen L; Tong H; Wang K; Zhao J; Song F; Yang H; Wei X; Jiao Z
Bioengineered; 2022 Apr; 13(4):11026-11041. PubMed ID: 35475392
[TBL] [Abstract][Full Text] [Related]
17. FGD5-AS1 Inhibits Osteoarthritis Development by Modulating miR-302d-3p/TGFBR2 Axis.
Yang Y; Sun Z; Liu F; Bai Y; Wu F
Cartilage; 2021 Dec; 13(2_suppl):1412S-1420S. PubMed ID: 33834880
[TBL] [Abstract][Full Text] [Related]
18. FGD5-AS1 facilitates glioblastoma progression by activation of Wnt/β-catenin signaling via regulating miR-129-5p/HNRNPK axis.
Wu L; Zhu X; Song Z; Guo M; Liang J; Yan D
Life Sci; 2020 Sep; 256():117998. PubMed ID: 32585241
[TBL] [Abstract][Full Text] [Related]
19. LncRNA FGD5-AS1 promotes tumor growth by regulating MCL1 via sponging miR-153-3p in oral cancer.
Ge C; Dong J; Chu Y; Cao S; Zhang J; Wei J
Aging (Albany NY); 2020 Jul; 12(14):14355-14364. PubMed ID: 32675387
[TBL] [Abstract][Full Text] [Related]
20. LncRNA FGD5-AS1 Promotes Abdominal Aortic Aneurysm Growth Through the Activation of MMP3 in Vascular Smooth Muscle Cells.
Xu Z; Lang D; Wang D; Hu S; Yang L
Int Heart J; 2023 May; 64(3):470-482. PubMed ID: 37197924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]